Enanta Pharmaceuticals (ENTA) PT Lowered to $44 at SVB Leerink
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $13.90 -1.35%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Join SI Premium – FREE
SVB Leerink analyst Roanna Ruiz lowered the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $44.00 (from $58.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
- CLSA Downgrades Jiangsu Yanghe Brewery (002304:CH) to Hold (3)
- CLSA Upgrades Taiyo Yuden Co Ltd (6976:JP) (TYOYY) to High-Conviction Outperform (1)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
